Our diverse network of BioTech companies represents the cutting edge of biotechnology, pharmaceuticals, and life sciences, each contributing uniquely to the advancement of human health and innovation. From 12-15 Molecular Diagnostics and 23andMe, which focus on early disease detection and personalized genetic testing, to 858 Therapeutics and Abcuro, which develop groundbreaking cancer therapies and precision immunotherapies, these organizations are tackling some of the most pressing medical challenges. Companies like 48Hour Discovery and Atomic AI accelerate drug discovery through advanced screening and AI-driven insights, while Agios and Alector pioneer metabolic and neurodegenerative disease treatments. Others, such as Agragene and Algenol, extend their expertise to agricultural biotechnology and renewable energy, demonstrating the far-reaching impact of biotech innovation. Collectively, these companies are driving progress in diagnostics, therapeutics, gene editing, regenerative medicine, and beyond, shaping a healthier and more sustainable future.
Our BioTech Network (companies we are currently in contact with):
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.